Alprazolam and Exposure for Panic Disorder with Agoraphobia: Attribution of Improvement to Medication Predicts Subsequent Relapse
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Patients with panic disorder plus agoraphobia had 8 weeks of drug treatment (alprazolam or placebo) plus psychological treatment (exposure or relaxation). At the end of treatment at week 8, 40 patients who had become much/very much improved rated how much their gains were attributable to medication or to their own efforts. During the tapering-off to week 16, and treatment-free follow-up to week 43, patients who at week 8 had attributed their gains to medication and felt less confident in coping without tablets had more severe withdrawal symptoms and greater loss of gains than did patients who at week 8 had attributed their gains to their own efforts during treatment. Baseline illness severity, greater age, higher expectations from drug treatment, and more side-effects of drugs during treatment all predicted more external attributions (i.e. to the effect of drugs) but did not independently predict relapse. Patients on alprazolam compared with placebo had more drug attributions. Though drug attributions predicted relapse in both alprazolam and placebo groups, predictions were stronger in the alprazolam group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801
Self-citationBallenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Marks, I. M., Swinson, R. P., Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.6.776 · Cited by 478
Self-citationClomipramine, self-exposure and therapist-aided exposure for obsessive–compulsive rituals
Marks, I. M., Lelliott, P., Basoglu, M., Noshirvani, H., Monteiro, W., Cohen, D., & Kasvikis, Y. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.152.4.522 · Cited by 255
Self-citationPecknold, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290043006 · Cited by 204
Alprazolam and diazepam: addiction potential
Juergens, S. (1991) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(91)90026-7 · Cited by 46 · cited 1×
“This may reflect the fact that aipra zolam has a rapid onset of action and so is one of the most reinforcing benzodiazepines (Apelt eta!, 1990; Juergens, 1991).”
BackgroundA prospective study of panic and anxiety in agoraphobia with panic disorder
Başoǧlu, M., Marks, I. M., & Şengün, S. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.1.57 · Cited by 40
Self-citationPreference for alprazolam as opposed to diazepam in benzodiazepine-dependent psychiatric inpatients
Apelt, S., Schmauss, C., & Emrich, H. (1990) · Pharmacopsychiatry · doi:10.1055/s-2007-1014486 · Cited by 12
Cited by
The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science
Holmes, E. A., Ghaderi, A., Harmer, C. J., Ramchandani, P. G., Cuijpers, P., Morrison, A. P., Roiser, J. P., Bockting, C. L. H., O'Connor, R. C., Shafran, R., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30513-8 · Cited by 624
Marks, I. M., Swinson, R. P., Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.6.776 · Cited by 478
Self-citationCognitive-behavioral therapy for social anxiety disorder: Current status and future directions
Heimberg, R. G. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01183-0 · Cited by 351
Foa, E. B., Franklin, M. E., & Moser, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01552-4 · Cited by 219
“" Furthermore, in a secondary analysis from the Marks et al (1993) study, Basoglu (1994) found that patients who at the end of 8 weeks of treatment attributed their gains to medication (either placebo or alprazolam) were more likely to relapse than those patients who attributed their gains to their…”
MethodTHEORETICAL FOUNDATIONS OF COGNITIVE-BEHAVIOR THERAPY FOR ANXIETY AND DEPRESSION
Brewin, C. R. (1996) · Annual Review of Psychology · doi:10.1146/annurev.psych.47.1.33 · Cited by 184
Self-citation
Metadata
- Authors
- Başoglu, M., Marks, I. M., Kiliç, C., Swinson, R. P., Noshirvani, H., Kuch, K., O'Sullivan, G., & Brewin, C. R.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1994-05
- Volume
- 164
- Issue
- 5
- Pages
- 652-659
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W1990406703
- Cited by
- 112
- References
- 8
- FWCI
- 11.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alprazolam and Exposure for Panic Disorder with Agoraphobia: Attribution of Improvement to Medication Predicts Subsequent Relapse. https://app.cochat.ai/papers/10.1192/bjp.164.5.652
- The paper
- Başoglu, M., Marks, I. M., Kiliç, C., Swinson, R. P., Noshirvani, H., Kuch, K., O'Sullivan, G., & Brewin, C. R. (1994). Alprazolam and Exposure for Panic Disorder with Agoraphobia: Attribution of Improvement to Medication Predicts Subsequent Relapse. British Journal of Psychiatry. https://doi.org/10.1192/bjp.164.5.652
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.